SurfingMASH
@surfing_mash
Drug developers, investors, researchers, and corporate executives wrestle weekly to understand what is happening in commercial development of MASH medications.
ID: 1346840791818399744
https://surfingmash.com 06-01-2021 15:27:38
1,1K Tweet
565 Takipรงi
227 Takip Edilen
. S5 ๐ฆ๐ฃ๐๐๐๐๐ ๐ญโ Reviewing EASL Congress: ๐ ๐ถ๐ธ๐ฒ ๐๐ฒ๐๐ฒ๐น Roger Green Roger Green speaks with FattyLiverAlliance Founder and CEO Mike Betel Michael Betel on the day before the EASL Congress officially opens. The discussion includes sessions Mike attended and one he
S5 SPECIAL 4 - ๐ฅ๐ฒ๐๐ถ๐ฒ๐๐ถ๐ป๐ด ๐๐๐ฆ๐ ๐๐ผ๐ป๐ด๐ฟ๐ฒ๐๐: Sven Francque Roger Green speaks with Hepatology Key Opinion Leader and EASL Educational Councillor Sven Francque 90 minutes after the EASL Congress closed. The discussion covers Clinical Practice Guidelines, drug
S5-E24 - ๐ ๐ฉ๐ถ๐ฒ๐ ๐ผ๐ณ ๐ ๐๐ฆ๐๐: Looking Back at EASL Congress From Six Weeks Later PharmaNest Founder and CEO Mathieu Petitjean and Global LIver Institute Vice President of Liver Programs Jeff McIntyre join Roger Green for 1:1 interviews exploring their key takeaways and
S5-E24.1 - EASL Congress Six Weeks Later: Mathieu Petitjean's Key Takeaways PharmaNest Inc Founder and CEO Mathieu Petitjean joins Roger Green to discuss key takeaways for his business from EASL Congress 2024. surfingmash.com/s5-e24-1-easl-โฆ #EASLCongress #KeyTakeaways #PharmaNest
S5-E24.2 - EASL Congress Six Weeks Later: Mathieu Petitjean's Key Implications PharmaNest Inc Founder and CEO Mathieu Petitjean joins Roger Green to discuss key implications for his business from what he learned at EASL Congress 2024. surfingmash.com/s5-e24-2-easl-โฆ #EASLCongress
S5-E24.3 - EASL Congress Six Weeks Later: Jeff McIntyre's Key Takeaways Global Liver Institute Institute Vice President of Liver Programs Jeff McIntyre joins Roger Green to discuss what he considers key takeaways for GLI from EASL Congress 2024. surfingmash.com/s5-e24-3-easl-โฆ #EASLCongress
S5 - E24.4 - EASL Congress Six Weeks Later: Jeff McIntyre's Key Implications for GLI In the second half of Roger Green's interview with Global Liver Institute Institute Vice President, Liver Programs Jeff McIntyre, Jeff discusses the implications of his key EASL Congress takeaways for GLI
S5-E25 - Reviewing Expert Recommendations on the Use of Resmetirom Maru Rinella Maru Rinella MD, corresponding author for the recent expert panel recommendations on resmetirom, joins the Surfers to discuss key points of the recommendations and the rationale behind them.
๐ค๐๐ฒ๐๐๐ถ๐ผ๐ป ๐ผ๐ณ ๐ง๐ต๐ฒ ๐ช๐ฒ๐ฒ๐ธ: โWhich approach will more significantly impact resmetirom treatment: using NITs to identify Advanced NASH patients or continuing therapy until disease progression?โ ANSWER HERE: surfingmash.com/question-of-thโฆ #surfingmash #QuestionOfTheWeek